Linda Muul

A Progress Report on the Treatment of 157 Patients with Advanced Cancer Using Lymphokine-Activated Killer Cells and Interleukin-2 or High-Dose Interleukin-2 Alone

Steven A. Rosenberg, Michael T. Lotze, Linda Muul et al. · New England Journal of Medicine · 1987 · 2.8K citations

Pharmacy, Immunology, Oncology +14

Observations on the Systemic Administration of Autologous Lymphokine-Activated Killer Cells and Recombinant Interleukin-2 to Patients with Metastatic Cancer

Steven A. Rosenberg, Michael T. Lotze, Linda Muul et al. · New England Journal of Medicine · 1985 · 2.6K citations

Medicine, Immunology, Oncology +15

Isolated allogeneic bone marrow-derived mesenchymal cells engraft and stimulate growth in children with osteogenesis imperfecta: Implications for cell therapy of bone

Edwin M. Horwitz, Patricia Gordon, Winston K. K. Koo et al. · Proceedings of the National Academy of Sciences · 2002 · 1.6K citations · Full text

Medicine, Immunology, Cell Therapy +16

T Lymphocyte-Directed Gene Therapy for ADA ⁻ SCID: Initial Trial Results After 4 Years

R. Michael Blaese, Kenneth W. Culver, A. Dusty Miller et al. · Science · 1995 · 1.5K citations

Medicine, Immunology, Molecular Medicine +16

Therapy of malignant brain tumors by intratumoral implantation of retroviral vector-producing cells

Zvi Ram, Kenneth W. Culver, Eric M. Oshiro et al. · Nature Medicine · 1997 · 683 citations

Medicine, Cancer Biology, Oncology +16